nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP1A2—chronic obstructive pulmonary disease	0.403	1	CbGaD
Apixaban—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0452	0.107	CbGbCtD
Apixaban—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0452	0.107	CbGbCtD
Apixaban—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0408	0.0965	CbGbCtD
Apixaban—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0376	0.0888	CbGbCtD
Apixaban—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0376	0.0888	CbGbCtD
Apixaban—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0355	0.0838	CbGbCtD
Apixaban—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0288	0.0681	CbGbCtD
Apixaban—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0285	0.0673	CbGbCtD
Apixaban—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0195	0.046	CbGbCtD
Apixaban—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.019	0.0449	CbGbCtD
Apixaban—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0186	0.0439	CbGbCtD
Apixaban—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0166	0.0391	CbGbCtD
Apixaban—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0162	0.0383	CbGbCtD
Apixaban—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0153	0.0362	CbGbCtD
Apixaban—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00972	0.023	CbGbCtD
Apixaban—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00918	0.0217	CbGbCtD
Apixaban—Retroperitoneal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00526	0.0642	CcSEcCtD
Apixaban—Retroperitoneal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00526	0.0642	CcSEcCtD
Apixaban—Haematochezia—Roflumilast—chronic obstructive pulmonary disease	0.0047	0.0573	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.0281	CcSEcCtD
Apixaban—Haematemesis—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.0222	CcSEcCtD
Apixaban—Contusion—Montelukast—chronic obstructive pulmonary disease	0.00108	0.0132	CcSEcCtD
Apixaban—Rectal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.013	CcSEcCtD
Apixaban—Rectal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00106	0.013	CcSEcCtD
Apixaban—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.001	0.0122	CcSEcCtD
Apixaban—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.000938	0.0115	CcSEcCtD
Apixaban—Melaena—Formoterol—chronic obstructive pulmonary disease	0.000938	0.0115	CcSEcCtD
Apixaban—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.000934	0.0114	CcSEcCtD
Apixaban—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000858	0.0105	CcSEcCtD
Apixaban—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000856	0.0105	CcSEcCtD
Apixaban—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000757	0.00924	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000699	0.00854	CcSEcCtD
Apixaban—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000673	0.00822	CcSEcCtD
Apixaban—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00808	CcSEcCtD
Apixaban—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000656	0.008	CcSEcCtD
Apixaban—Petechiae—Prednisolone—chronic obstructive pulmonary disease	0.000632	0.00772	CcSEcCtD
Apixaban—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.00766	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000615	0.00751	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000602	0.00735	CcSEcCtD
Apixaban—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.0072	CcSEcCtD
Apixaban—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000587	0.00717	CcSEcCtD
Apixaban—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00715	CcSEcCtD
Apixaban—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00711	CcSEcCtD
Apixaban—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000558	0.00682	CcSEcCtD
Apixaban—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00662	CcSEcCtD
Apixaban—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00659	CcSEcCtD
Apixaban—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00657	CcSEcCtD
Apixaban—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00625	CcSEcCtD
Apixaban—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00625	CcSEcCtD
Apixaban—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00607	CcSEcCtD
Apixaban—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000497	0.00607	CcSEcCtD
Apixaban—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00606	CcSEcCtD
Apixaban—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.0059	CcSEcCtD
Apixaban—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00584	CcSEcCtD
Apixaban—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00581	CcSEcCtD
Apixaban—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00581	CcSEcCtD
Apixaban—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00578	CcSEcCtD
Apixaban—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00578	CcSEcCtD
Apixaban—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00577	CcSEcCtD
Apixaban—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00577	CcSEcCtD
Apixaban—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00047	0.00574	CcSEcCtD
Apixaban—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000467	0.00569	CcSEcCtD
Apixaban—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00569	CcSEcCtD
Apixaban—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00567	CcSEcCtD
Apixaban—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00565	CcSEcCtD
Apixaban—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00561	CcSEcCtD
Apixaban—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00559	CcSEcCtD
Apixaban—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.00558	CcSEcCtD
Apixaban—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00556	CcSEcCtD
Apixaban—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.0055	CcSEcCtD
Apixaban—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00549	CcSEcCtD
Apixaban—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00546	CcSEcCtD
Apixaban—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000446	0.00545	CcSEcCtD
Apixaban—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00545	CcSEcCtD
Apixaban—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000443	0.00541	CcSEcCtD
Apixaban—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00539	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00044	0.00537	CcSEcCtD
Apixaban—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00532	CcSEcCtD
Apixaban—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00532	CcSEcCtD
Apixaban—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00531	CcSEcCtD
Apixaban—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00531	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.0053	CcSEcCtD
Apixaban—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00529	CcSEcCtD
Apixaban—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00521	CcSEcCtD
Apixaban—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000426	0.0052	CcSEcCtD
Apixaban—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.0052	CcSEcCtD
Apixaban—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000425	0.00519	CcSEcCtD
Apixaban—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000421	0.00513	CcSEcCtD
Apixaban—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.0051	CcSEcCtD
Apixaban—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00508	CcSEcCtD
Apixaban—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00504	CcSEcCtD
Apixaban—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.00503	CcSEcCtD
Apixaban—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00502	CcSEcCtD
Apixaban—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00501	CcSEcCtD
Apixaban—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000401	0.00489	CcSEcCtD
Apixaban—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00447	CcSEcCtD
Apixaban—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00434	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00433	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00433	CcSEcCtD
Apixaban—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00425	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00424	CcSEcCtD
Apixaban—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00418	CcSEcCtD
Apixaban—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00418	CcSEcCtD
Apixaban—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000342	0.00417	CcSEcCtD
Apixaban—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000336	0.0041	CcSEcCtD
Apixaban—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.0041	CcSEcCtD
Apixaban—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000336	0.0041	CcSEcCtD
Apixaban—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00406	CcSEcCtD
Apixaban—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00406	CcSEcCtD
Apixaban—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00405	CcSEcCtD
Apixaban—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00402	CcSEcCtD
Apixaban—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00401	CcSEcCtD
Apixaban—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00398	CcSEcCtD
Apixaban—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00395	CcSEcCtD
Apixaban—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00391	CcSEcCtD
Apixaban—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00391	CcSEcCtD
Apixaban—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00389	CcSEcCtD
Apixaban—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00387	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00385	CcSEcCtD
Apixaban—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00384	CcSEcCtD
Apixaban—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00382	CcSEcCtD
Apixaban—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00369	CcSEcCtD
Apixaban—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00363	CcSEcCtD
Apixaban—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00361	CcSEcCtD
Apixaban—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00361	CcSEcCtD
Apixaban—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00354	CcSEcCtD
Apixaban—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00346	CcSEcCtD
Apixaban—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00346	CcSEcCtD
Apixaban—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00343	CcSEcCtD
Apixaban—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00341	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00335	CcSEcCtD
Apixaban—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00327	CcSEcCtD
Apixaban—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00326	CcSEcCtD
Apixaban—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.00326	CcSEcCtD
Apixaban—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.0032	CcSEcCtD
Apixaban—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00319	CcSEcCtD
Apixaban—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00308	CcSEcCtD
Apixaban—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00308	CcSEcCtD
Apixaban—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.00308	CcSEcCtD
Apixaban—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00302	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00295	CcSEcCtD
Apixaban—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00291	CcSEcCtD
Apixaban—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00277	CcSEcCtD
Apixaban—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00277	CcSEcCtD
Apixaban—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00271	CcSEcCtD
Apixaban—Rash—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00264	CcSEcCtD
Apixaban—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00264	CcSEcCtD
Apixaban—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00263	CcSEcCtD
Apixaban—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00263	CcSEcCtD
Apixaban—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00261	CcSEcCtD
Apixaban—Rash—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00258	CcSEcCtD
Apixaban—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00258	CcSEcCtD
Apixaban—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00249	CcSEcCtD
Apixaban—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.00249	CcSEcCtD
Apixaban—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00249	CcSEcCtD
Apixaban—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00248	CcSEcCtD
Apixaban—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00248	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00244	CcSEcCtD
Apixaban—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00243	CcSEcCtD
Apixaban—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00235	CcSEcCtD
Apixaban—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00233	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00232	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00228	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00226	CcSEcCtD
Apixaban—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00223	CcSEcCtD
Apixaban—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00216	CcSEcCtD
Apixaban—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000172	0.0021	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00209	CcSEcCtD
Apixaban—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00186	CcSEcCtD
Apixaban—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00181	CcSEcCtD
Apixaban—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00177	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00171	CcSEcCtD
Apixaban—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00167	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00165	CcSEcCtD
Apixaban—Shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00162	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00161	CcSEcCtD
Apixaban—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.0016	CcSEcCtD
Apixaban—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.0015	CcSEcCtD
Apixaban—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00143	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00143	CcSEcCtD
Apixaban—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00135	CcSEcCtD
Apixaban—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.93e-05	0.00121	CcSEcCtD
Apixaban—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.31e-05	0.00102	CbGpPWpGaD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.24e-05	0.00101	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.11e-05	0.000996	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.01e-05	0.000984	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9e-05	0.000984	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	8.95e-05	0.000978	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.94e-05	0.000976	CbGpPWpGaD
Apixaban—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.00109	CcSEcCtD
Apixaban—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.89e-05	0.000971	CbGpPWpGaD
Apixaban—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.77e-05	0.000958	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.74e-05	0.000955	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.62e-05	0.000942	CbGpPWpGaD
Apixaban—Rash—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00104	CcSEcCtD
Apixaban—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.00104	CcSEcCtD
Apixaban—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.48e-05	0.000927	CbGpPWpGaD
Apixaban—F10—Hemostasis—MMP1—chronic obstructive pulmonary disease	8.47e-05	0.000925	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.46e-05	0.000925	CbGpPWpGaD
Apixaban—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.43e-05	0.000921	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.34e-05	0.000911	CbGpPWpGaD
Apixaban—F10—Hemostasis—PLAU—chronic obstructive pulmonary disease	8.31e-05	0.000908	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.13e-05	0.000889	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.04e-05	0.000878	CbGpPWpGaD
Apixaban—Nausea—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000978	CcSEcCtD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.65e-05	0.000836	CbGpPWpGaD
Apixaban—F10—Hemostasis—NOS2—chronic obstructive pulmonary disease	7.64e-05	0.000834	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.57e-05	0.000827	CbGpPWpGaD
Apixaban—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.51e-05	0.00082	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.47e-05	0.000816	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.42e-05	0.00081	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.33e-05	0.000801	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.29e-05	0.000797	CbGpPWpGaD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.2e-05	0.000787	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.19e-05	0.000786	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	7.13e-05	0.000779	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.02e-05	0.000768	CbGpPWpGaD
Apixaban—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.9e-05	0.000754	CbGpPWpGaD
Apixaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.86e-05	0.000749	CbGpPWpGaD
Apixaban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.77e-05	0.000739	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.76e-05	0.000739	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.7e-05	0.000732	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.67e-05	0.000728	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	6.66e-05	0.000728	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.61e-05	0.000722	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	6.45e-05	0.000704	CbGpPWpGaD
Apixaban—F10—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	6.43e-05	0.000703	CbGpPWpGaD
Apixaban—F10—Hemostasis—ALB—chronic obstructive pulmonary disease	6.42e-05	0.000701	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.4e-05	0.0007	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.35e-05	0.000694	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.34e-05	0.000692	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.32e-05	0.00069	CbGpPWpGaD
Apixaban—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.26e-05	0.000685	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.26e-05	0.000684	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.24e-05	0.000682	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.23e-05	0.000681	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.17e-05	0.000674	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.16e-05	0.000673	CbGpPWpGaD
Apixaban—F10—Hemostasis—NOS3—chronic obstructive pulmonary disease	6.14e-05	0.000671	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.08e-05	0.000664	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.08e-05	0.000664	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.8e-05	0.000634	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.75e-05	0.000629	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.000625	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.72e-05	0.000625	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.64e-05	0.000616	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.63e-05	0.000615	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.56e-05	0.000607	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.000607	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.5e-05	0.000601	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.43e-05	0.000593	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.21e-05	0.00057	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.19e-05	0.000567	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.18e-05	0.000566	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.15e-05	0.000563	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.15e-05	0.000563	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.14e-05	0.000562	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.11e-05	0.000558	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.11e-05	0.000558	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.07e-05	0.000554	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.94e-05	0.00054	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.91e-05	0.000537	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.89e-05	0.000534	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.84e-05	0.000529	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.83e-05	0.000528	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.83e-05	0.000528	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.73e-05	0.000516	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.72e-05	0.000516	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.72e-05	0.000516	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.66e-05	0.000509	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.63e-05	0.000506	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.63e-05	0.000506	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.6e-05	0.000502	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.000489	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.45e-05	0.000487	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.43e-05	0.000484	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.42e-05	0.000483	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.42e-05	0.000483	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.41e-05	0.000482	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.41e-05	0.000482	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.39e-05	0.00048	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.33e-05	0.000473	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.33e-05	0.000473	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.28e-05	0.000468	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.27e-05	0.000467	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.27e-05	0.000466	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.18e-05	0.000457	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.06e-05	0.000444	CbGpPWpGaD
Apixaban—F10—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.06e-05	0.000444	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.04e-05	0.000441	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.01e-05	0.000438	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.98e-05	0.000435	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.98e-05	0.000434	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.95e-05	0.000432	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.86e-05	0.000421	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.84e-05	0.00042	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.83e-05	0.000418	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.77e-05	0.000412	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.77e-05	0.000412	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.66e-05	0.0004	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.6e-05	0.000394	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.59e-05	0.000392	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.39e-05	0.00037	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.00037	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.34e-05	0.000365	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—chronic obstructive pulmonary disease	3.34e-05	0.000365	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.29e-05	0.00036	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.16e-05	0.000345	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.11e-05	0.00034	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.08e-05	0.000336	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.07e-05	0.000336	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.06e-05	0.000335	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.95e-05	0.000323	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.93e-05	0.00032	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.000318	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.91e-05	0.000318	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.85e-05	0.000312	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.82e-05	0.000308	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.65e-05	0.00029	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.62e-05	0.000286	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.6e-05	0.000284	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.57e-05	0.000281	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ALB—chronic obstructive pulmonary disease	2.56e-05	0.00028	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.55e-05	0.000279	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.55e-05	0.000278	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.51e-05	0.000274	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.48e-05	0.000272	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.48e-05	0.000271	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.45e-05	0.000268	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.39e-05	0.000261	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.38e-05	0.00026	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.37e-05	0.000259	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.000259	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.32e-05	0.000254	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.31e-05	0.000252	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000247	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.2e-05	0.00024	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.00024	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.16e-05	0.000236	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000231	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000228	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.06e-05	0.000226	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.04e-05	0.000223	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.98e-05	0.000217	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.98e-05	0.000216	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.9e-05	0.000207	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.000206	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.000203	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.84e-05	0.000202	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000197	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.000194	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.77e-05	0.000193	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.00019	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000188	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.000188	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000177	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.000175	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.57e-05	0.000172	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.56e-05	0.00017	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.00017	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	0.000168	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.53e-05	0.000167	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000166	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.5e-05	0.000163	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.000161	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.44e-05	0.000157	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.42e-05	0.000156	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000154	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000152	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.00015	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000148	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	0.000147	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000141	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.28e-05	0.00014	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.27e-05	0.000139	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000137	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000137	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	0.000136	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000134	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000134	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.19e-05	0.00013	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000128	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000126	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.15e-05	0.000125	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000125	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000123	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	0.000119	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.000118	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000117	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000116	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000115	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000113	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.99e-06	0.000109	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.92e-06	0.000108	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.86e-06	0.000108	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.77e-06	0.000107	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.64e-06	0.000105	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.51e-06	0.000104	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.41e-06	0.000103	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.41e-06	0.000103	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.28e-06	0.000101	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.86e-06	9.68e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.79e-06	9.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.67e-06	9.47e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.65e-06	9.45e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.4e-06	9.18e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.36e-06	9.14e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.27e-06	9.03e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.2e-06	8.96e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.08e-06	8.83e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.66e-06	8.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.54e-06	8.24e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.51e-06	8.21e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.41e-06	8.09e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.38e-06	8.07e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.06e-06	7.72e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.95e-06	7.59e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.9e-06	7.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.54e-06	7.15e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.4e-06	6.99e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.12e-06	6.68e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.8e-06	6.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.72e-06	6.25e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.71e-06	6.24e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.57e-06	6.09e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.46e-06	5.97e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.33e-06	5.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.33e-06	5.82e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.21e-06	5.69e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.05e-06	5.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-06	5.44e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.45e-06	4.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.25e-06	4.65e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.43e-06	3.75e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.28e-06	3.59e-05	CbGpPWpGaD
